| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
| mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
| mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |